← FDA Drug Approvals (Drugs@FDA)

ARGATROBAN

NDA · New Drug Application · Sponsor: FRESENIUS KABI USA · Approved 2015-03-23

Drug application

FDA Application #
NDA201811
Application type
New Drug Application
Brand name
ARGATROBAN
Generic name
ARGATROBAN
Active ingredients
ARGATROBAN
Dosage form
INJECTABLE
Route
INJECTION
Marketing status
Discontinued
Sponsor
FRESENIUS KABI USA
Manufacturer
Fresenius Kabi USA, LLC
First approval
2015-03-23

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown